Compare Bank of Montreal (BMO) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of Montreal vs Inovio Pharmaceuticals Inc — how do they compare? Bank of Montreal trades at $182.04 (market cap $126.83B), while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). The key difference: Bank of Montreal is far larger — about 1614.6× Inovio Pharmaceuticals Inc's market cap, and Bank of Montreal pays a 2.69% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| BMO | INO | |
|---|---|---|
Market Cap | $126.83B | $78.55M |
Sector | Financials | Health |
52-Week High | $183.65 | $2.87 |
52-Week Low | $112.54 | $0.66 |
Dividend Yield | 2.69% | — |
Enterprise Value | — | $49.56M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bank of Montreal
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
